• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.

作者信息

Cogger Kenneth O

出版信息

J Clin Psychopharmacol. 2007 Aug;27(4):418-20. doi: 10.1097/01.jcp.0000280315.81366.f8.

DOI:10.1097/01.jcp.0000280315.81366.f8
PMID:17632240
Abstract
摘要

相似文献

1
Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.评分者改进：一种估计效应量增加和降低临床试验成本的方法。
J Clin Psychopharmacol. 2007 Aug;27(4):418-20. doi: 10.1097/01.jcp.0000280315.81366.f8.
2
A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.抗抑郁试验中临床总体印象变化的比较性荟萃分析。
J Nerv Ment Dis. 2006 Nov;194(11):845-52. doi: 10.1097/01.nmd.0000244554.91259.27.
3
From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.从试错到试验模拟。第1部分：基于模型的抗抑郁药物研发的重要性。
Clin Pharmacol Ther. 2009 Sep;86(3):248-54. doi: 10.1038/clpt.2009.105. Epub 2009 Aug 5.
4
Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
J Clin Psychopharmacol. 2009 Apr;29(2):197-8; author reply 198-9. doi: 10.1097/JCP.0b013e318199f275.
5
The mousetrap: managing the placebo effect in antidepressant trials.捕鼠器：在抗抑郁药物试验中控制安慰剂效应
Mol Interv. 2002 Apr;2(2):72-6. doi: 10.1124/mi.2.2.72.
6
Generalizability of antidepressant efficacy trials.抗抑郁药疗效试验的可推广性。
Essent Psychopharmacol. 2004;6(1):45-58.
7
Factors contributing to failed trials of new agents: can technology prevent some problems?
J Clin Psychiatry. 2002;63 Suppl 2:8-13.
8
[The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Fortschr Med. 1982 Dec 2;100(45):2111-7.
9
Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.利用抑郁症临床试验的纵向数据评估其结果量表的可靠性。
J Psychiatr Res. 2009 Apr;43(7):730-8. doi: 10.1016/j.jpsychires.2008.09.010. Epub 2008 Nov 4.
10
Are the effects of rater training sustainable? Results from a multicenter clinical trial.评估者培训的效果是否可持续？一项多中心临床试验的结果。
J Clin Psychopharmacol. 2007 Oct;27(5):534-5. doi: 10.1097/JCP.0b013e31814f4d71.

引用本文的文献

1
Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews.与使用传统半结构化访谈的试验相比，在使用结构化、录音和评估评分者访谈（SIGMA-RAPS）的抗抑郁临床试验中，抗抑郁药和安慰剂的变化幅度。
Psychopharmacology (Berl). 2014 Nov;231(22):4301-7. doi: 10.1007/s00213-014-3584-4. Epub 2014 Apr 26.
2
Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?凤凰涅槃：阿尔茨海默病失败药物能否卷土重来？
Alzheimers Dement. 2013 Jan;9(1):50-7. doi: 10.1016/j.jalz.2012.01.007. Epub 2012 Mar 30.
3
Increasing the success rate for Alzheimer's disease drug discovery and development.
提高阿尔茨海默病药物研发成功率。
Expert Opin Drug Discov. 2012 Apr;7(4):367-70. doi: 10.1517/17460441.2012.672409. Epub 2012 Mar 23.
4
Lost in translation: neuropsychiatric drug development.迷失在翻译中：神经精神药物研发。
Sci Transl Med. 2010 Dec 8;2(61):61rv6. doi: 10.1126/scitranslmed.3000446.
5
Phenserine efficacy in Alzheimer's disease.苯乙嗪治疗阿尔茨海默病的疗效。
J Alzheimers Dis. 2010;22(4):1201-8. doi: 10.3233/JAD-2010-101311.
6
Why so few drugs for Alzheimer's disease? Are methods failing drugs?为什么治疗老年痴呆症的药物这么少？是方法让药物研发失败了吗？
Curr Alzheimer Res. 2010 Nov;7(7):642-51. doi: 10.2174/156720510793499075.
7
Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?神经精神科临床试验：它们应该适应现实世界的实践，还是为临床实践设定标准？
J Clin Psychopharmacol. 2009 Feb;29(1):56-64. doi: 10.1097/JCP.0b013e318192e2fa.
8
Alzheimer's disease drug development: old problems require new priorities.阿尔茨海默病药物研发：老问题需要新重点。
CNS Neurol Disord Drug Targets. 2008 Dec;7(6):499-511. doi: 10.2174/187152708787122950.
9
Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?为什么这么多治疗阿尔茨海默病的药物在研发中失败？是时候采用新方法和新实践了吗？
J Alzheimers Dis. 2008 Oct;15(2):303-25. doi: 10.3233/jad-2008-15213.
10
Alzheimer's disease drug development in 2008 and beyond: problems and opportunities.2008年及以后的阿尔茨海默病药物研发：问题与机遇
Curr Alzheimer Res. 2008 Aug;5(4):346-57. doi: 10.2174/156720508785132299.